These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24966060)

  • 21. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension.
    Michaels AD; Chatterjee K; De Marco T
    J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.
    Chen HH; AbouEzzeddine OF; Anstrom KJ; Givertz MM; Bart BA; Felker GM; Hernandez AF; Lee KL; Braunwald E; Redfield MM;
    Circ Heart Fail; 2013 Sep; 6(5):1087-94. PubMed ID: 24046475
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction.
    Zhao Q; Wu TG; Lin Y; Li B; Luo JY; Wang LX
    Heart Vessels; 2010 Mar; 25(2):97-103. PubMed ID: 20339970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction.
    Sica D; Oren RM; Gottwald MD; Mills RM;
    Clin Cardiol; 2010 Jun; 33(6):330-6. PubMed ID: 20556802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Xiong B; Wang C; Yao Y; Huang Y; Tan J; Cao Y; Zou Y; Huang J
    PLoS One; 2015; 10(6):e0131326. PubMed ID: 26107522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.
    Cunningham JW; Sun JL; Mc Causland FR; Ly S; Anstrom KJ; Lindenfeld J; Givertz MM; Stevenson LW; Lakdawala NK
    Clin Cardiol; 2020 Jan; 43(1):43-49. PubMed ID: 31721249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nesiritide speeds recovery time for heart failure patients.
    Morrow T
    Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
    [No Abstract]   [Full Text] [Related]  

  • 29. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
    Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
    J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of nesiritide in patients with critical cardiac disease.
    Bronicki RA; Domico M; Checchia PA; Kennedy CE; Akcan-Arikan A
    Cardiol Young; 2017 Oct; 27(8):1577-1584. PubMed ID: 28641607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiographic predictors of change in left ventricular diastolic pressure in heart failure patients receiving nesiritide.
    Weeks SG; Shapiro M; Foster E; Michaels AD
    Echocardiography; 2008 Sep; 25(8):849-55. PubMed ID: 18986412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.
    Armstrong PW; Rouleau JL
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):30B-2B. PubMed ID: 18629387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis.
    Zhao X; Zhang DQ; Song R; Zhang G
    J Int Med Res; 2020 Jan; 48(1):300060519897194. PubMed ID: 31948318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial.
    Cox ZL; Collins SP; Aaron M; Hernandez GA; Iii ATM; Davidson BT; Fowler M; Lindsell CJ; Jr FEH; Jenkins CA; Kampe C; Miller KF; Stubblefield WB; Lindenfeld J
    Am Heart J; 2021 Feb; 232():116-124. PubMed ID: 33144086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis.
    Mitaka C; Kudo T; Haraguchi G; Tomita M
    Crit Care; 2011; 15(5):R258. PubMed ID: 22032777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial.
    Butler J; Anstrom KJ; Felker GM; Givertz MM; Kalogeropoulos AP; Konstam MA; Mann DL; Margulies KB; McNulty SE; Mentz RJ; Redfield MM; Tang WHW; Whellan DJ; Shah M; Desvigne-Nickens P; Hernandez AF; Braunwald E;
    JAMA Cardiol; 2017 Sep; 2(9):950-958. PubMed ID: 28700781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.